TNFRSF8 and mature T-cell and NK-cell non-Hodgkin lymphoma: CD30 also overexpresses in a portion of peripheral T-cell lymphoma (PTCL), adult T-cell leukemia/lymphoma (ATL), NK lymphoma, and diffuse large B-cell lymphoma (DLBCL), in which clinical studies of BV therapy have been examined.